320589-95-5Relevant academic research and scientific papers
Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression
-
, (2008/06/13)
The invention concerns Use of a compound of formula (I) or a physiologically acceptable salt, solvate or derivative thereof, in the manufacture of a medicament for the treatment of diseases ameliorated by LDL-r upregulation, to novel compounds and pharmac
Pharmaceutical compositions
-
Page 8, (2010/02/03)
The invention relates to a method for screening therapeutic agents, defined as SCAP antagonists, for use in combating diseases associated with elevated lipid levels, said method comprising detecting or assaying the extent or result of transcriptional acti
